Cargando…

2684. Characteristics of mpox patients treated with Tecovirimat: a single center review

BACKGROUND: The 2022 mpox outbreak disproportionately affected men who have sex with men (MSM), and communities of color. Tecovirimat, which was FDA-approved for the treatment of smallpox in 2018, was made available to treat mpox via an Expanded Access Investigational New Drug protocol through the C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vargas, Robert, Fernandez, Jennifer, Taylor, David, Green, Tondria, Won, Sarah Y, Sha, Beverly E, Guarin, Laura Hernandez, Shankaran, Shivanjali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678383/ http://dx.doi.org/10.1093/ofid/ofad500.2295

Ejemplares similares

Tecovirimat for the treatment of severe Mpox in Germany
por: Hermanussen, Lennart, et al.
Publicado: (2023)

1790. Characteristics of Patients with Mpox Treated with Tecovirimat during the 2022 Outbreak in Puerto Rico
por: Gonzalez, Hector J Melendez, et al.
Publicado: (2023)

Tecovirimat Resistance in Mpox Patients, United States, 2022–2023
por: Smith, Todd G., et al.
Publicado: (2023)

Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022
por: Contag, Caitlin A., et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of Patients With Mpox Who Received Tecovirimat in a New York City Health System
por: Vo, Christopher, et al.
Publicado: (2023)

Tecovirimat use among patients with monkeypox (mpox) in Alameda County, California, June–October 2022
por: Ouyang, Megan, et al.
Publicado: (2023)

Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA
por: Lash, Maura K., et al.
Publicado: (2023)

Tecovirimat for monkeypox
por: Halani, Sheliza, et al.
Publicado: (2022)

Monkeypox treatment: Is tecovirimat the answer?
por: Niaz, Faizan, et al.
Publicado: (2022)

Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report
por: Martinez, Andres E., et al.
Publicado: (2023)

Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat
por: Hernandez, Loren E, et al.
Publicado: (2022)

Navigating the expanded access investigational new drug protocol for tecovirimat: lessons learned from a public–private hospital partnership during the 2022 NYC mpox outbreak
por: Mgbako, Ofole, et al.
Publicado: (2023)

Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection
por: Fatima, Maurish, et al.
Publicado: (2023)

PB2684: QUALITY OF LIFE IMPAIRMENT IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA WHO SUFFERED FROM RUSSIAN MILITARY AGGRESSION IN UKRAINE: A SINGLE CENTER EXPERIENCE
por: Lymanets, Tetiana, et al.
Publicado: (2023)

2007. To Treat or Not to Treat: Does a More Sensitive and Specific Testing Methodology Make the Treatment Decision More Clear?
por: Kulla, Bakri, et al.
Publicado: (2018)

Treatment with tecovirimat of the first two cases of monkeypox in Japan
por: Inada, Makoto, et al.
Publicado: (2023)

Monkeypox Proctitis: A Case of Targeted Treatment With Tecovirimat
por: Patel, Premalkumar, et al.
Publicado: (2023)

Therapeutics for treating mpox in humans
por: Fox, Tilly, et al.
Publicado: (2023)

Bacterial Sinusitis in the COVID-19 Era: A Reminder for Antibiotic Stewardship
por: Subramani, Manasa, et al.
Publicado: (2021)

1402. Expand accessibility of monoclonal antibody in COVID-19 among different ethnicities and races.
por: Farooq, Hina, et al.
Publicado: (2022)

Tecovirimat for Monkeypox in the Central African Republic under Expanded Access
por: Mbrenga, Festus, et al.
Publicado: (2022)

Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge()()
por: Russo, Andrew T., et al.
Publicado: (2020)

2684. The Prospective Pilot Study of Infectious Complication Surveillance in Active Systemic Lupus Erythematosus Patients with Intense Immunosuppressive Therapy: Cellular Response and Clinical Outcomes
por: Rotjanapan, Porpon, et al.
Publicado: (2019)

Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
por: Matias, Wilfredo R, et al.
Publicado: (2022)

Le técovirimat dans le traitement de la variole simienne
por: Halani, Sheliza, et al.
Publicado: (2023)

In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat
por: Nunes, Desiree dos Santos, et al.
Publicado: (2023)

A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome
por: Viguier, Clément, et al.
Publicado: (2022)

Development of a predictive model for identifying women vulnerable to HIV in Chicago
por: Friedman, Eleanor E., et al.
Publicado: (2023)

Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak
por: Perzia, Brittany, et al.
Publicado: (2022)

Monkeypox infection and resolution after treatment with tecovirimat in two patients with HIV disease
por: Beatty, Norman L., et al.
Publicado: (2022)

Epidemiological and clinical characteristics of mpox cases: reply
por: Pascom, Ana Roberta, et al.
Publicado: (2023)

Epidemiological and clinical characteristics of mpox cases: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022
por: Vallejo-Plaza, Alberto, et al.
Publicado: (2022)

Immune Reconstitution Inflammatory Syndrome Reaction in Patient on Long-Term Prednisone
por: Sahgal, Savina, et al.
Publicado: (2023)

Effect of Surfactants and Polymers on the Dissolution Behavior of Supersaturable Tecovirimat-4-Hydroxybenzoic Acid Cocrystals
por: Feng, Yumiao, et al.
Publicado: (2021)

Epidemiological and clinical characteristics of Mpox Cases in Serbia in 2022
por: Jovanovic, V, et al.
Publicado: (2023)

A Rare Case of Locally Contracted Cutaneous Corynebacterium diphtheriae
por: Trubin, Marc, et al.
Publicado: (2023)

A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak
por: Almehmadi, Mazen, et al.
Publicado: (2022)

Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus
por: Chen, Zhang-Ren, et al.
Publicado: (2022)

Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
por: Mondi, Annalisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vjqtf7p842nj9lnppbuc1fq2fj